![Sierk Poetting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sierk Poetting
Direttore operativo presso
BIONTECH SE
Patrimonio netto: 50 M $ in data 30/06/2026
Profilo
Attualmente, Sierk Ptting occupa la posizione di Chief Operating & Financial Officer di BioNTech SE e di Co-Managing Director di JPT Peptide Technologies GmbH e di Managing Director di BioNTech Small Molecules GmbH (entrambe controllate di BioNTech SE). In passato il Dr. Ptting ha ricoperto la posizione di VP & Chief Financial Officer-Sandoz Division presso Novartis AG e Chief Financial Officer & Vice President per Sandoz, Inc. (una filiale di Novartis AG) e consulente presso McKinsey GmbH & Co. KG. Ha conseguito una laurea presso l'Università dell'Arizona e un dottorato presso la Ludwig-Maximilians-Universitt Mnchen.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIONTECH SE 0,22% | 12/05/2026 | 542.539 ( 0,22% ) | 50 M $ | 30/06/2026 |
Posizioni attive di Sierk Poetting
| Società | Posizione | Inizio |
|---|---|---|
| BIONTECH SE | Direttore operativo | 01/09/2014 |
JPT Peptide Technologies GmbH
 JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Amministratore Delegato | - |
BioNTech Europe GmbH
 BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Amministratore Delegato | - |
IQM Finland Oy
 IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Presidente | 03/03/2022 |
BioNTech Diagnostics GmbH
 BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Amministratore Delegato | - |
BioNTech Delivery Technologies GmbH
 BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Amministratore Delegato | - |
Precedenti posizioni note di Sierk Poetting
| Società | Posizione | Fine |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/08/2014 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Direttore Finanziario/CFO | - |
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | - |
Formazione di Sierk Poetting
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPT Peptide Technologies GmbH
JPT Peptide Technologies GmbH Medical SpecialtiesHealth Technology Provides innovative peptide based products and services for vaccine development, immune monitoring and peptide biomarker discovery | Health Technology |
BioNTech Diagnostics GmbH
BioNTech Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops peptide synthesis solutions | Commercial Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
McKinsey GmbH & Co. KG
McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
BioNTech Europe GmbH
BioNTech Europe GmbH BiotechnologyHealth Technology Engages in the research and development of synthetic compounds against cancer and other diseases | Health Technology |
IQM Finland Oy
IQM Finland Oy Computer Processing HardwareElectronic Technology Develops quantum computers | Electronic Technology |
BioNTech Delivery Technologies GmbH
BioNTech Delivery Technologies GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development of immunotherapies | Commercial Services |
